Ocular Phenotype and Complications in Patients with Tuberous Sclerosis Complex (TSC)

被引:0
|
作者
Zweipfenning, Florian [1 ]
Toelle, Sandra P. [2 ]
Gerth-Kahlert, Christina [1 ]
机构
[1] Univ Spital Zurich, Augenklin, Frauenklin Str 24, CH-8091 Zurich, Switzerland
[2] Univ Kinderspital Zurich, Abt Neuropadiatrie, Zurich, Switzerland
关键词
tuberous sclerosis complex; inverse optic atrophy; vigabatrin toxicity; RETINAL ASTROCYTOMAS; VIGABATRIN TOXICITY; RECOMMENDATIONS;
D O I
10.1055/a-0804-1816
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background Evaluation and comparison of the ocular phenotype in patients diagnosed with tuberous sclerosis complex (TSC). Analysis of ocular complications during follow-up. Patients and Methods A retrospective chart review was performed of patients with TSC who had received an ocular examination at the eye clinic of the University Hospital Zurich. Data were analysed on visual acuity (VA) assessment, refraction, anterior and posterior eye examination including the distinction of different types of hamartomas and, when available, visual fields. The study was approved by the Cantonal Ethics Committee of Zurich. Results A total of 30 patients who were diagnosed with TSC (19 female, 11 male) were included in the analysis. The age at first examination varied from 7 months to 44 years (mean 13.3 years, standard deviation 11.31). 17/30 patients received a follow-up examination between 4 months and 19 years (mean 4.3 years, standard deviation 5.24). Data of VA were available in 26/30 patients, of whom 22 had normal vision in both eyes. The causes of reduced VA in the 4 patients were: complications of a subependymal giant cell astrocytoma followed by a bilateral optic nerve atrophy; vigabatrin-associated optic atrophy; anterior segment dysgenesis; unilateral amblyopia. Adequate VA testing was not possible in 4 patients because of intellectual disabilities. Retinal hamartomas were described in 15/30 patients: 8 unilateral, 7 bilateral. The flat hamartoma type was described in 10/15 patients, the multinodular type in 6/15 patients. Conclusions The ocular phenotype in our patient cohort shows similar TSC involvement to that described in the literature. Patients diagnosed with TSC require regular ophthalmic examinations to diagnose secondary ocular complications, such as papilloedema, severe vision loss or visual field constriction.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 50 条
  • [21] CAUSES OF MORTALITY IN INDIVIDUALS WITH TUBEROUS SCLEROSIS COMPLEX (TSC)
    Amin, Sam
    Lux, Andrew
    Calder, Nuala
    Laugharne, Matthew
    Osborne, John
    O'Callaghan, Finbar
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [22] Tuberous Sclerosis Complex (TSC): Renal and Extrarenal Imaging
    Gupta, Shiva
    Kang, Hyunseon C.
    Faria, Silvana C.
    Choyke, Peter L.
    Kundra, Vikas
    ACADEMIC RADIOLOGY, 2022, 29 (03) : 439 - 449
  • [23] Mutational analysis of the Tuberous Sclerosis Complex (TSC) genes
    Rendtorff, ND
    Mogensen, B
    Brondum-Nielsen, K
    Schwartz, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 96 - 96
  • [24] TUBEROUS SCLEROSIS COMPLEX (TSC): A NORWEGIAN INTERDISCIPLINARY GUIDE
    Tuft, M.
    Olsen, T. Rath
    EPILEPSIA, 2015, 56 : 91 - 91
  • [25] Neuropsychological Attention Deficits in Tuberous Sclerosis Complex (TSC)
    de Vries, Petrus J.
    Gardiner, Julian
    Bolton, Patrick F.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (03) : 387 - 395
  • [26] Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex
    Yamamoto, T
    Pipo, JR
    Feng, JH
    Takeda, H
    Nanba, E
    Ninomiya, H
    Ohno, K
    BRAIN & DEVELOPMENT, 2002, 24 (04): : 227 - 230
  • [27] Identification of TSC1 and TSC2 Mutations in Korean Patients With Tuberous Sclerosis Complex
    Jang, Mi-Ae
    Hong, Seung Bong
    Lee, Jee Hun
    Lee, Mun Hyang
    Chung, Man Pyo
    Shin, Hyung-Jin
    Kim, Jong-Won
    Ki, Chang-Seok
    PEDIATRIC NEUROLOGY, 2012, 46 (04) : 222 - 224
  • [28] The Adult Phenotype of Tuberous Sclerosis Complex
    Nathan, Neera
    Burke, Kristina
    Trickett, Cory
    Moss, Joel
    Darling, Thomas N.
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (02) : 278 - +
  • [29] Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
    Rosengren, Thomas
    Nanhoe, Santoesha
    Dufner de Almeida, Luis Gustavo
    Schonewolf-Greulich, Bitten
    Larsen, Lasse Jonsgaard
    Brunbjerg Hey, Caroline Amalie
    Duno, Morten
    Ek, Jakob
    Risom, Lotte
    Nellist, Mark
    Moller, Lisbeth Birk
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [30] EVEROLIMUS THERAPY REDUCES THE VOLUME OF TUBERS OF PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX (TSC)
    Franz, D. N.
    Agricola, K. D.
    Tudor, C. A.
    Krueger, D. A.
    EPILEPSIA, 2011, 52 : 178 - 178